Company news

Bioelectronics Corp. (OTC:BIEL) news

Bioelectronics Corp. news releases on 6ix. Latest, May 2, 2018: BioElectronics to Meet with FDA To Seek Expanded OTC Clearances

View Bioelectronics Corp. →

Press releases — page 2

BioElectronics to Meet with FDA To Seek Expanded OTC Clearances

May 2, 2018

BioElectronics VP of Sales Discusses Pre & Post-operative Pain Relief Surgical Program in “Stock Day” Interview

April 26, 2018

BioElectronics Announces Knee Replacement Clinical Study

March 19, 2018

BioElectronics Vice President of Sales Discusses Opioids and the Alternative Drug Free ActiPatch® Pain Therapy

January 22, 2018

BioElectronics Announces Expanded Menstrual Pain Study

January 16, 2018

BioElectronics and CARE Pharmacies to Provide Pain Consultations and ActiPatch, the Drug Free Alternative to Opioids

January 9, 2018

BioElectronics ActiPatch Drug Free Pain Therapy Receives United Kingdom National Health System Payment Coverage

January 4, 2018

BioElectronics Announces ActiPatch: Over-The-Counter Alternative to Opioids

December 12, 2017

BioElectronics Announces the Launch of the ‘Try & Tell’ Program

December 7, 2017

Andy Whelan, President BioElectronics Updates Uptick Newswire “Stock Day” Listeners

November 20, 2017

BioElectronics Vietnam Distributor, PharmEvo, Announces Electroceutical Symposium, Expansion into Cambodia & The Maldives

November 13, 2017

BioElectronics to Showcase Products at World's Largest Medical Tradeshow

November 9, 2017

BioElectronics Announces Drug Free Solution to the Opioid Crisis (ActiPatch)

November 6, 2017

BioElectronics Announces Independent Back Pain Clinical Study Pulsed Neuromodulation Therapy (ActiPatch) for Chronic Musculoskeletal Lower Back Pain

October 16, 2017

BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

September 25, 2017

UPDATE - Letter from BioElectronics' (OTC PINK: BIEL) President to Investors

August 29, 2017

Letter from BioElectronics' (OTC PINK: BIEL) President to Investors

August 28, 2017

UPDATE - BioElectronics' President Discusses Company's Many Opportunities

August 22, 2017

BioElectronics' President Discusses Company's Many Opportunities

August 22, 2017

BioElectronics Engages Keith Nalepka As Vice President of Sales and Marketing

August 22, 2017

BioElectronics Announces Update on Migraine Clinical Study Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

August 8, 2017

BioElectronics Wins the Orthopedics This Week 2017 Sports Medicine Technology Award

August 2, 2017

BioElectronics to Present at 2017 UK Community Pharmacists' Meeting

June 30, 2017

BioElectronics Announces Health Economics Study

June 29, 2017

BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy)

May 30, 2017

BioElectronics Expands into Tesco in the UK Market

May 17, 2017

BioElectronics President Interviewed By UpTick Radio: A Discussion on how Wearable Technology can Mitigate the Opioid Addiction Crisis

April 20, 2017

BioElectronics to Launch Educational Strategy: ActiPatch as the First Line of Defense Against Opioid Pain Medication

April 18, 2017

BioElectronics to Present Research at 13th World Congress of International Neuromodulation Society

April 11, 2017

BioElectronics Participates At 2017 Australian Pain Society 37th Annual Scientific Meeting

April 7, 2017

BioElectronics' ActiPatch Exhibits At Australia's Major Pharmaceutical Event

March 13, 2017

BioElectronics Appoints an Indian Subcontinent Distributor

March 6, 2017

BioElectronics Initiates US Over-the-Counter (Non Prescription) Sales Of Its FDA Cleared Drug-free Pain Relief Medical Devices

March 2, 2017

BioElectronics Corporation Letter from the President

February 28, 2017

BioElectronics Announces ActiPatch(R) Available on Amazon

February 9, 2017

BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch(R) Musculoskeletal Pain Therapy

February 6, 2017

BioElectronics' ActiPatch(R) Nonprescription Medical Device That Reduces Pain 52% and Medication Use 50% including Opioids

December 12, 2016

BioElectronics Appoints Southeast Asia Distributor

November 1, 2016

BioElectronics President Interviewed by the StockRadio.com Discusses BioElectronics, the Science of the Chronic Pain market, and Drug Use

October 27, 2016

BioElectronics Comments on its U.S. FDA's OTC Market Clearance Application

October 10, 2016

BioElectronics' ActiPatch® Drug-free Pain Therapy to be Featured at Pharmacy Week in Trinidad & Tobago W.I.

October 3, 2016

BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication

September 28, 2016

BioElectronics Launches ActiPatch®, Musculoskeletal Pain Therapy In Sweden

September 13, 2016

BioElectronics' Drug-free ActiPatch® Pain Therapy

April 28, 2016

BioElectronics' ActiPatch® Chronic Pain Therapy Featured In UK's Leading Daily Mail Newspaper Health Section

April 25, 2016

BioElectronics President Interviewed by the StockRadio.com

April 11, 2016

BioElectronics Drug-free Chronic Pain Therapy Observation Study Results

March 29, 2016

BioElectronics Appoints Evomed as Australian and New Zealand Distributor

March 21, 2016

BioElectronics Wins "Best OTC Marketing Campaign on a Small Budget"

March 15, 2016

BioElectronics Invited to Present Chronic Pain Patient Observation Study at the British Pain Society Congress

March 9, 2016

← Newer · Older →